Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study | Zendy

Luther A. Bartelt | Zendy; Alena J. Markmann | Zendy; Bridget Nelson | Zendy; Jessica Keys | Zendy; Heather T. Root | Zendy; Heather Henderson | Zendy; JoAnn Kuruc | Zendy; Caroline Baker | Zendy; D. Ryan Bhowmik | Zendy; Yixuan J. Hou | Zendy; Lakshmanane Premkumar | Zendy; Caleb Cornaby | Zendy; John L. Schmitz | Zendy; Susan R. Weiss | Zendy; Yara Park | Zendy; Ralph S. Baric | Zendy; Aravinda M. de Silva | Zendy; Anne M. Lachiewicz | Zendy; Sonia Napravnik | Zendy; David van Duin | Zendy; David M. Margolis | Zendy

Open Access

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study

Author(s) -

Luther A. Bartelt,

Alena J. Markmann,

Bridget Nelson,

Jessica Keys,

Heather T. Root,

Heather Henderson,

JoAnn Kuruc,

Caroline Baker,

D. Ryan Bhowmik,

Yixuan J. Hou,

Lakshmanane Premkumar,

Caleb Cornaby,

John L. Schmitz,

Susan R. Weiss,

Yara Park,

Ralph S. Baric,

Aravinda M. de Silva,

Anne M. Lachiewicz,

Sonia Napravnik,

David van Duin,

David M. Margolis

Publication year - 2022

Publication title -

carolina digital repository (university of north carolina at chapel hill)

Language(s) - English

DOI - 10.17615/27bq-xc46

Subject(s) - convalescent plasma , virology , neutralizing antibody , titer , covid-19 , antibody , coronavirus , medicine , antibody titer , virus , immunology , infectious disease (medical specialty) , disease , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research